Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp
Start free

UiPath, Inc. (PATH) Guidance & Earnings Results

On 2026-09-03 UiPath, Inc. raised guidance: "Q3 FY2027 revenue $440-445M; Q3 FY2027 ARR $1.992-1.997B; Q3 FY2027 non-GAAP operating income ~$100M. FY2027 revenue $1.789-1.794B; FY2027 ARR $2.065-2.070B; FY2027 non-GAAP operating income…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason

PATHUiPath, Inc.Follow PATH — free
Software - Infrastructure · Technology
—
Price chart with a free account
Market cap
7.4B
P/E TTM
21.1
Dividend yield
—
52-week
—
Next earnings
1 Dec, in 37 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
3 Sep 26RaisedQ3 FY2027 revenue $440-445M; Q3 FY2027 ARR $1.992-1.997B; Q3 FY2027 non-GAAP operating income ~$100M. FY2027 revenue $1.789-1.794B; FY2027 ARR $2.065-2.070B; FY2027 non-GAAP operating income ~$445M.
28 May 26RaisedFull-year FY2027 revenue guidance raised to $1.776B-$1.781B; ARR guidance raised to $2.058B-$2.063B; non-GAAP operating income guidance of ~$430M · full year
11 Mar 26RaisedQ1 FY2027 revenue $395M-$400M; FY2027 revenue $1.754B-$1.759B; ARR $2.051B-$2.056B · full year
3 Dec 25RaisedQ4 FY2026 revenue guidance $462M-$467M; ARR $1.844B-$1.849B; non-GAAP operating income ~$140M.
4 Sep 25RaisedQ3 revenue $390-395M; FY revenue $1.571-1.576B · full year

UiPath, Inc. — questions

What guidance did UiPath, Inc. give?
On 2026-09-03: "Q3 FY2027 revenue $440-445M; Q3 FY2027 ARR $1.992-1.997B; Q3 FY2027 non-GAAP operating income ~$100M. FY2027 revenue $1.789-1.794B; FY2027 ARR $2.065-2.070B; FY2027 non-GAAP operating income ~$445M."
When does UiPath, Inc. report earnings?
UiPath, Inc.'s next earnings report is expected on 2026-12-01.

Every figure on this page comes from UiPath, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.